1. It is a histone deacetylase inhibitor.
- Cutaneous T cell lymphoma.
3. Mechanism of action:
It leads to the re-expression of genes that are previously silenced in cutaneous T cell lymphoma, those re-expressed genes encode transcription factors which promote T cell differentiation instead of proliferation leading to tumor regression.